Jane Street’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $32.1M | Sell |
109,600
-195,800
| -64% | -$64.4M | ﹤0.01% | 1380 |
|
|
2025
Q4 | $107M | Buy |
305,400
+37,700
| +14% | +$12.7M | 0.02% | 553 |
|
|
2025
Q3 | $86.5M | Buy |
267,700
+32,300
| +14% | +$10M | 0.01% | 660 |
|
|
2025
Q2 | $91.6M | Buy |
235,400
+109,000
| +86% | +$43.8M | 0.02% | 495 |
|
|
2025
Q1 | $55M | Buy |
126,400
+24,800
| +24% | +$9.96M | 0.01% | 624 |
|
|
2024
Q4 | $37.5M | Buy |
101,600
+36,900
| +57% | +$15.4M | 0.01% | 848 |
|
|
2024
Q3 | $33.6M | Buy |
64,700
+7,100
| +12% | +$3.79M | 0.01% | 897 |
|
|
2024
Q2 | $31.2M | Sell |
57,600
-24,500
| -30% | -$13M | 0.01% | 957 |
|
|
2024
Q1 | $42.6M | Buy |
82,100
+32,500
| +66% | +$16.2M | 0.01% | 715 |
|
|
2023
Q4 | $23.4M | Sell |
49,600
-8,800
| -15% | -$4.07M | 0.01% | 1149 |
|
|
2023
Q3 | $25.4M | Sell |
58,400
-3,200
| -5% | -$1.45M | 0.01% | 916 |
|
|
2023
Q2 | $27.4M | Buy |
61,600
+7,100
| +13% | +$3.28M | 0.01% | 953 |
|
|
2023
Q1 | $25.1M | Sell |
54,500
-27,700
| -34% | -$13.2M | 0.01% | 856 |
|
|
2022
Q4 | $42.2M | Sell |
82,200
-23,400
| -22% | -$11.9M | 0.02% | 610 |
|
|
2022
Q3 | $48M | Sell |
105,600
-25,100
| -19% | -$12M | 0.02% | 541 |
|
|
2022
Q2 | $63.1M | Buy |
130,700
+60,200
| +85% | +$29.8M | 0.03% | 451 |
|
|
2022
Q1 | $34.6M | Buy |
70,500
+9,500
| +16% | +$4.34M | 0.01% | 883 |
|
|
2021
Q4 | $28.3M | Sell |
61,000
-46,000
| -43% | -$19.4M | 0.01% | 954 |
|
|
2021
Q3 | $39.9M | Buy |
107,000
+18,400
| +21% | +$6.99M | 0.01% | 699 |
|
|
2021
Q2 | $33.8M | Sell |
88,600
-37,500
| -30% | -$14.3M | 0.01% | 745 |
|
|
2021
Q1 | $45.3M | Buy |
126,100
+73,500
| +140% | +$23.6M | 0.02% | 527 |
|
|
2020
Q4 | $16.9M | Sell |
52,600
-17,800
| -25% | -$5.46M | 0.01% | 984 |
|
|
2020
Q3 | $18.9M | Sell |
70,400
-36,800
| -34% | -$9.9M | 0.01% | 808 |
|
|
2020
Q2 | $28.2M | Buy |
107,200
+83,000
| +343% | +$22.1M | 0.02% | 580 |
|
|
2020
Q1 | $5.49M | Sell |
24,200
-1,800
| -7% | -$491K | 0.01% | 1117 |
|
|
2019
Q4 | $7.85M | Sell |
26,000
-1,700
| -6% | -$468K | 0.01% | 768 |
|
|
2019
Q3 | $6.65M | Sell |
27,700
-2,200
| -7% | -$603K | 0.01% | 807 |
|
|
2019
Q2 | $8.44M | Buy |
29,900
+4,900
| +20% | +$1.34M | 0.01% | 723 |
|
|
2019
Q1 | $7.17M | Sell |
25,000
-8,600
| -26% | -$2.49M | 0.01% | 892 |
|
|
2018
Q4 | $8.82M | Sell |
33,600
-3,300
| -9% | -$907K | 0.02% | 644 |
|
|
2018
Q3 | $10.1M | Buy |
36,900
+24,700
| +202% | +$6.41M | 0.02% | 598 |
|
|
2018
Q2 | $2.9M | Buy |
12,200
+1,500
| +14% | +$347K | 0.01% | 1524 |
|
|
2018
Q1 | $2.35M | Buy |
+10,700
| New | +$2.51M | 0.01% | 1657 |
|
|
2017
Q4 | – | Sell |
-2,200
| Closed | -$418K | – | 4692 |
|
|
2017
Q3 | $418K | Buy |
+2,200
| New | +$419K | ﹤0.01% | 3325 |
|
|
2017
Q2 | – | Sell |
-22,100
| Closed | -$3.65M | – | 4445 |
|
|
2017
Q1 | $3.65M | Buy |
22,100
+6,900
| +45% | +$1.1M | 0.02% | 914 |
|
|
2016
Q4 | $2.19M | Buy |
15,200
+2,200
| +17% | +$295K | 0.01% | 1238 |
|
|
2016
Q3 | $1.63M | Buy |
13,000
+10,700
| +465% | +$1.38M | 0.01% | 1406 |
|
|
2016
Q2 | $302K | Buy |
+2,300
| New | +$315K | ﹤0.01% | 3314 |
|
|
2015
Q4 | – | Sell |
-35,100
| Closed | -$4.91M | – | 4086 |
|
|
2015
Q3 | $4.91M | Buy |
35,100
+33,000
| +1,571% | +$4.96M | 0.03% | 460 |
|
|
2015
Q2 | $345K | Buy |
2,100
+600
| +40% | +$95.9K | ﹤0.01% | 2653 |
|
|
2015
Q1 | $232K | Buy |
+1,500
| New | +$214K | ﹤0.01% | 2746 |
|
Other funds holding ELV
VCM
VPM
Jane Street's ELV Position: Q1 2026 in Review
Jane Street increased its Elevance Health (ELV) stake by 2,018% in Q1 2026, buying an estimated $47.3M and bringing the position to 151,157 shares worth $44.3M. The position accounts for 0.01% of the portfolio, ranked #1145.
Jane Street first reported a position in ELV in Q2 2013 and has held it in 49 quarters since. The position peaked at $84.7M in Q2 2024. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Jane Street held 151,157 shares of Elevance Health worth $44.3M as of Q1 2026.
- Jane Street bought 144,020 Elevance Health shares in Q1 2026, an estimated $47.3M.
- Elevance Health made up 0.01% of Jane Street's portfolio in Q1 2026, its #1145 holding.
- Jane Street first reported a position in Elevance Health in Q2 2013 and has held it in 49 quarters since.
- Jane Street's Elevance Health position peaked at $84.7M in Q2 2024.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.